We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Growth of AIDS Virus Enhanced by Methamphetamine

By Biotechdaily staff writers
Posted on 20 Jun 2002
Research done on a feline model that mimics human AIDS has shown that exposure to methamphetamine increases by as much as 15-fold the ability of the feline immunodeficiency virus (FIV) to replicate in the cat brain. More...
In the study, which was published in the June 2002 issue of the Journal of NeuroVirolgy, cat brain tissues were exposed to a concentration of methamphetamine equal to the average level in an adult human abuser's bloodstream.

"We found that after about two weeks of chronic methamphetamine exposure, the ability of these infected cell lines to mass-produce virus increases dramatically,” explained Dr. Michael Podell of Ohio State University (Columbus, USA), professor of veterinary clinical sciences and neurosciences.

Before beginning the methamphetamine experiments the investigators established a system for infecting astrocytes isolated from feline brain tissue with the FIV virus. They found that initial infection required that the astrocytes be associated with peripheral blood mononuclear cells (PBMCs). Once it had infected the astrocytes, the virus began to rapidly reproduce, an observation that was contrary to the accepted belief that FIV resulted only in a latent infection.

"We found that the reason the virus multiplies so rapidly is that it mutates into a different strain,” Dr. Podell said, one that is not dependent on the presence of PBMCs. This virus strain appears to be completely independent of any immune system interaction. "That means that any drugs intended to interfere with, or influence the immune system may have absolutely no effect on the astrocyte infection in the brain,” added Dr. Podell. Infection by both virus strains was dependent upon a functional astrocyte CXCR4 receptor.

Methamphetamine significantly increased FIV replication in feline astrocytes for cell-associated infection only, with no effect on peripheral blood mononuclear cells. This viral replication was related to proviral copy number, suggesting that the effect of methamphetamine was at the viral entry or integration into host genome levels, but not at the translational level. Thus, FIV infection of the brain in the presence of methamphetamine resulted in enhanced astrocyte viral replication, producing a more rapid and increased brain viral load.



Related Links:
Ohio State University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.